Skip to main content
. 2021 Feb 23;28:17–23. doi: 10.1016/j.ctro.2021.02.002

Table 3.

Acute treatment-related adverse events in comparison to RTOG 0529 and RTOG 9811

Adverse Event Current Series RTOG 0529 RTOG 9811
Grade 2+
GI/GU 39% 77% 77%
Dermatologic 67% 75% 83%
GI 38% 73% 73%
GU 5% 15% 20%
Hematologic 54% 73% 85%
Pain 44%



Grade 3+
GI/GU 17% 21% 37%
GI 17% 21% 36%
GU 0% 2% 3%
Dermatologic 16% 23% 49%
Hematologic 32% 58% 62%
Pain 15%

Abbreviations: GI, gastrointestinal; GU, genitourinary.